China Resources Boya Bio-pharmaceutical Group – World Class Benchmarking
Company: China Resources Boya Bio-pharmaceutical Group Company Limited
Bloomberg ticker: 300294 SZ
Market cap: US$2,479m
Background: China Resources Boya Bio-pharmaceutical Group Company Limited manufactures pharmaceutical products. The Company mainly develops, produces, and sells blood products, diabetes drugs, anti-infective chemicals, biochemical drugs, and other products.
World Class Benchmarking of China Resources Boya Bio-pharmaceutical Group
- Profitable Growth rank of 4 was up compared to the prior period’s 5th rank
- This is above average performance compared to 410 medium Health Care companies worldwide
- Profitability rank of 4 was worse than its Growth rank of 3
- Profitability rank of 4 was the same compared to the prior period’s 4th rank
- This is above average performance compared to peers
- Growth rank of 3 was up compared to the prior period’s 5th rank
- This is above average performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.